KG
TAK icon

Kilter Group’s Takeda Pharmaceutical TAK Stock Holding History

Kilter Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Sell
693
-249
-26% -$4.12K ﹤0.01% 446
2026
Q1 		$17.4K Buy
942
+913
+3,148% +$16K 0.01% 257
2025
Q4 		$453 Buy
+29
New +$415 ﹤0.01% 1205

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Kilter Group's TAK Position: Q2 2026 in Review

Kilter Group reduced its Takeda Pharmaceutical (TAK) stake by 26% in Q2 2026, selling an estimated $4.12K and leaving 693 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #446.

Kilter Group first reported a position in TAK in Q4 2025 and has held it in 3 quarters since. The position peaked at $17.4K in Q1 2026. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Kilter Group held 693 shares of Takeda Pharmaceutical worth $11.1K as of Q2 2026.
  • Kilter Group sold 249 Takeda Pharmaceutical shares in Q2 2026, an estimated $4.12K.
  • Takeda Pharmaceutical made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #446 holding.
  • Kilter Group first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • Kilter Group's Takeda Pharmaceutical position peaked at $17.4K in Q1 2026.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.